找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Prevention II; Hans-Jörg Senn,Ursula Kapp,Florian Otto Conference proceedings 2009 Springer-Verlag Berlin Heidelberg 2009 ER-negati

[复制链接]
楼主: Malnutrition
发表于 2025-3-25 06:46:05 | 显示全部楼层
发表于 2025-3-25 07:55:34 | 显示全部楼层
Calculi of Names: Free and Modalnoids (analogs of retinoids that bind and activate RXR receptors), tyrosine kinase inhibitors (such as EGFR inhibitors and dual kinase inhibitors that block EGFR and HER2/neu signaling), and cyclo-oxygenase 2 (COX-2) inhibitors all prevent ER-negative breast cancer in transgenic mice that develop ER
发表于 2025-3-25 11:53:19 | 显示全部楼层
发表于 2025-3-25 19:17:50 | 显示全部楼层
发表于 2025-3-25 21:45:16 | 显示全部楼层
发表于 2025-3-26 04:00:45 | 显示全部楼层
发表于 2025-3-26 08:14:15 | 显示全部楼层
0080-0015 Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on “Primary Therapy
发表于 2025-3-26 08:38:33 | 显示全部楼层
New Era for Robust Speech Recognitione trial. This warrants further research on fenretinide mechanisms of action and potential efficacy and provides the rationale for a phase III primary prevention trial in young women at high risk for breast cancer.
发表于 2025-3-26 13:43:04 | 显示全部楼层
Existence and Reference in Medieval Logicst, multicentre, randomised controlled clinical trial looking at the long-term chemopre-vention effect of esomeprazole with or without aspirin. More than 85% of the participants tolerated the medications at the initial intended doses, and the drop-out rate has been 7%; the interim analysis is due in 2011.
发表于 2025-3-26 17:29:28 | 显示全部楼层
Free Logic and Definite Descriptionsrophage-mediated immune surveillance. This observation and data demonstrating that non-steroidal anti-inflammatory drugs (NSAIDs) protect against prostate cancer provide the justification for trials of these two agents combined with short course intermittent anti-androgen therapy in populations at high risk of prostate cancer.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 22:45
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表